Cristin L. Rothfuss - 09 Mar 2026 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
EVP, General Counsel
Signature
/s/ Cristin L. Rothfuss
Issuer symbol
SRPT
Transactions as of
09 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 20:07:03 UTC
Previous filing
03 Mar 2026
Next filing
13 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rothfuss Cristin EVP, General Counsel 215 FIRST STREET, CAMBRIDGE /s/ Cristin L. Rothfuss 11 Mar 2026 0002046214

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability -484 -0.35% $16.95* 138,864 09 Mar 2026 Direct F1
transaction SRPT Common Stock Tax liability -346 -0.25% $16.95* 138,518 09 Mar 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022.
F2 Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023.